Effects of Exercise in Patients Undergoing Chemotherapy for Head and Neck Cancer: A Pilot Randomized Controlled Trial

Effects of Exercise in Patients Undergoing Chemotherapy for Head and Neck Cancer: A Pilot Randomized Controlled Trial

Background: Cisplatin administration may induce muscle atrophy, thereby reducing the fitness level of patients with head and neck cancer (HNC). To date, only animal studies have been conducted to test the effectiveness of exercise interventions in diminishing side effects of cisplatin. Aim: To deter...

Full description

Bibliographic Details
Main Authors:	Kuan-Yin Lin, Hui-Ching Cheng, Chia-Jui Yen, Ching-Hsia Hung, Yu-Ting Haung, Hsin-Lun Yang, Wan-Ting Cheng, Kun-Ling Tsai
Format:	Article
Language:	English
Published:	MDPI AG 2021-02-01
Series:	International Journal of Environmental Research and Public Health
Subjects:	head and neck cancer exercise training muscle strength chemotherapy
Online Access:	https://www.mdpi.com/1660-4601/18/3/1291

Similar Items

Effect of Exercise Training on Exercise Tolerance and Level of Oxidative Stress for Head and Neck Cancer Patients Following Chemotherapy
by: Chia-Jui Yen, et al.
Published: (2020-08-01)

Molecular Mechanisms of Chemotherapy Resistance in Head and Neck Cancers
by: Yuzuka Kanno, et al.
Published: (2021-05-01)

Recent advances in chemotherapy for head and neck cancers
by: Uma C Sambargi, et al.
Published: (2012-01-01)

The Effect of Hypnotherapy on Anticipatory Nausea in Head and Neck Cancer Patients Undergoing Chemotherapy
by: Dadi Hamdani, et al.
Published: (2020-12-01)

The impacts of intra-arterial chemotherapy on head and neck microvascular reconstruction
by: Chen-Hsiang Kuan, et al.
Published: (2020-10-01)

Safety and efficacy of weekly versus three-weekly paclitaxel plus platinum neoadjuvant chemotherapy in patients with locally advanced squamous cell head and neck carcinoma: A pilot study
by: Akash Mathur, et al.
Published: (2018-01-01)

New paste for severe stomatitis in patients undergoing head-and-neck cancer radiotherapy and/or chemotherapy with oral appliance
by: Ayumi Sakuramoto, et al.
Published: (2018-03-01)

Dose-dense TPF induction chemotherapy for locally advanced head and neck cancer: a phase II study
by: Ching-Yun Hsieh, et al.
Published: (2020-09-01)

An underestimated pitfall of oral candidiasis in head and neck cancer patients undergoing radiotherapy: an observation study
by: Imjai Chitapanarux, et al.
Published: (2021-07-01)

Carbon‐ion radiotherapy combined with chemotherapy for head and neck mucosal melanoma: Prospective observational study
by: Yukihiro Takayasu, et al.
Published: (2019-12-01)

The Slippery Role of Induction Chemotherapy in Head and Neck Cancer: Myth and Reality
by: Daris Ferrari, et al.
Published: (2020-01-01)

Therapeutic methods used in the treatment of malignant lymphomas of the head and neck
by: Mihail TUȘALIU, et al.
Published: (2018-09-01)

Insonation of Systemically Delivered Cisplatin-Loaded Microbubbles Significantly Attenuates Nephrotoxicity of Chemotherapy in Experimental Models of Head and Neck Cancer
by: Hang-Kang Chen, et al.
Published: (2018-09-01)

STUDY OF THE ROLE OF COMBINED RADIOTHERAPY & CHEMOTHERAPY IN TREATMENT OF SQUAMOUS CELL TUMORS OF HEAD AND NECK
by: A MOSALAEI
Published: (2003-12-01)

Analysis of chemotherapy effect on the second primary malignancy for head and neck cancer patients by a nomogram based on SEER database
by: Xinrong Li, et al.
Published: (2020-11-01)

RADIOCHEMOTHERAPY FOR ADVANCED HEAD AND NECK CARCINOMA – LJUBLJANA EXPERIENCE
by: Lojze Šmid, et al.
Published: (2002-12-01)

Pharmacokinetic-Based Chemotherapy Dosing in Advanced Head and Neck Cancer: A Mini Review
by: Abdelhamid Fouad, et al.
Published: (2019-06-01)

Blood neutrophil-to-lymphocyte ratio as a predictor of response to chemotherapy in head-and-neck cancers
by: Mohammad Hashemi-Bahremani, et al.
Published: (2019-01-01)

Molecular response to induction chemotherapy and its correlation with treatment outcome in head and neck cancer patients by means of NMR-based metabolomics
by: Łukasz Boguszewicz, et al.
Published: (2021-04-01)

Comparing high‐dose cisplatin with cisplatin‐based combination chemotherapy in definitive concurrent chemoradiation setting for locally advanced head and neck squamous cell carcinoma (LAHNSCC)
by: Muhammad Furqan, et al.
Published: (2019-06-01)

Safety and Efficacy of Salvage Neck Dissection Following Carbon-ion Radiotherapy with Chemotherapy for a Patient with Mucosal Malignant Melanoma of Head and Neck
by: Hidenori Suzuki, et al.
Published: (2020-02-01)

Induction chemotherapy with dose-modified docetaxel, cisplatin, and 5-fluorouracil in Asian patients with borderline resectable or unresectable head and neck cancer
by: Hung-Ming Wang, et al.
Published: (2017-03-01)

Oral health related quality of life in patients with head and neck tumors undergoing chemo and radiotherapy
by: Shahed Maghsudlu, et al.
Published: (2016-06-01)

Evaluation of head and neck cancer patients’ knowledge regarding complications of chemotherapy and radiotherapy in patients referring to Kerman University of Medical Sciences treatment centers
by: Molook Torabi Parizi, et al.
Published: (2018-09-01)

The Indian scenario of head and neck oncology - Challenging the dogmas
by: Vidisha Tuljapurkar, et al.
Published: (2016-01-01)

Dihydropyrimidine dehydrogenase mutation in neoadjuvant chemotherapy in head and neck cancers: Myth or reality?
by: Vijay M Patil, et al.
Published: (2016-01-01)

The Efficacy and Adverse Events in Patients with Head and Neck Cancer Following Radiotherapy Combined with S-1 Therapy: A Meta-Analysis
by: Hung-Sheng Shih, et al.
Published: (2021-06-01)

Radiotherapy for geriatric head-and-neck cancer patients: what is the value of standard treatment in the elderly?
by: Erik Haehl, et al.
Published: (2020-02-01)

Resensitization to Nivolumab after Intratumoral Chemotherapy in Recurrent Head and Neck Squamous Cell Cancer: A Report of 2 Cases
by: Aline Houessinon, et al.
Published: (2020-07-01)

An audit of the results of a triplet metronomic chemotherapy regimen incorporating a tyrosine kinase inhibitor in recurrent/metastatic head and neck cancers patients
by: Vijay M Patil, et al.
Published: (2016-01-01)

Predictive factors of toxicity of TPF induction chemotherapy for locally advanced head and neck cancers
by: Maureen Bernadach, et al.
Published: (2021-04-01)

The value of moderate dose escalation for re-irradiation of recurrent or second primary head-and-neck cancer
by: Alexander Rühle, et al.
Published: (2020-04-01)

Changes in carnitine levels through induction chemotherapy in head and neck cancer patients as a potential cause of therapy-related malaise
by: Tatsuya Ito, et al.
Published: (2021-06-01)

In vitro chemosensitivity of head and neck cancer cell lines
by: Schuler PJ, et al.
Published: (2010-08-01)

Weekly chemotherapy as first line treatment in frail head and neck cancer patients in the immunotherapy era
by: Andrea Botticelli, et al.
Published: (2021-07-01)

Emergency Imaging in the Head and Neck
by: Yannick De Brucker
Published: (2018-11-01)

The Impact of Active Nutritional Support for Head and Neck Cancer Patients Receiving Concurrent Chemoradiotherapy
by: Vutisiri Veerasarn, et al.
Published: (2019-12-01)

De-Escalation Strategies of (Chemo)Radiation for Head-and-Neck Squamous Cell Cancers—HPV and Beyond
by: Alexander Rühle, et al.
Published: (2021-05-01)

Editorial: Advances in the Systemic Therapy and Combined Modality Approaches for Head and Neck Cancer
by: Athanassios Argiris, et al.
Published: (2019-11-01)

Induction chemotherapy with paclitaxel and cisplatin to concurrent radiotherapy and weekly paclitaxel in the treatment of loco-regionally advanced, stage IV (M0), head and neck squamous cell carcinoma. Mature results of a prospective study
by: Pergolizzi Stefano, et al.
Published: (2011-11-01)

Cannot write session to /tmp/vufind_sessions/sess_mfh6phmkdvpmk2s4t2m3cdjrn7